NewEdge Advisors LLC Acquires 1,458 Shares of Humana Inc. $HUM

NewEdge Advisors LLC boosted its holdings in Humana Inc. (NYSE:HUMFree Report) by 85.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,174 shares of the insurance provider’s stock after purchasing an additional 1,458 shares during the quarter. NewEdge Advisors LLC’s holdings in Humana were worth $550,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Montag A & Associates Inc. grew its stake in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana in the 4th quarter worth about $27,000. Reflection Asset Management bought a new position in Humana in the 4th quarter worth about $29,000. Global Assets Advisory LLC purchased a new stake in Humana during the 1st quarter valued at about $38,000. Finally, Larson Financial Group LLC increased its stake in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. UBS Group assumed coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “buy” rating on the stock. Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price target for the company in a research report on Thursday, July 30th. Wolfe Research upgraded shares of Humana from a “peer perform” rating to an “outperform” rating in a report on Thursday, July 30th. Evercore raised Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective on the stock in a research report on Wednesday, July 29th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $425.00 target price on shares of Humana in a research note on Wednesday, June 3rd. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Humana presently has a consensus rating of “Hold” and an average target price of $395.22.

Check Out Our Latest Research Report on Humana

Humana Price Performance

HUM opened at $379.22 on Friday. The company’s 50-day simple moving average is $383.38 and its two-hundred day simple moving average is $281.59. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market capitalization of $45.54 billion, a P/E ratio of 35.88, a P/E/G ratio of 2.18 and a beta of 0.72. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same period in the previous year, the business posted $6.27 earnings per share. The business’s revenue for the quarter was up 26.2% on a year-over-year basis. As a group, analysts predict that Humana Inc. will post 9.08 EPS for the current year.

Humana Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Read More

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.